Viewing Study NCT06238635


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2025-12-29 @ 1:26 AM
Study NCT ID: NCT06238635
Status: RECRUITING
Last Update Posted: 2025-10-29
First Post: 2024-01-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dostarlimab and Cobolimab in Advanced Cervical Cancer
Sponsor: Meghan Shea
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-03-11
Start Date Type: ACTUAL
Primary Completion Date: 2026-12-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-07-15
Completion Date Type: ESTIMATED
First Submit Date: 2024-01-25
First Submit QC Date: None
Study First Post Date: 2024-02-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-10-27
Last Update Post Date: 2025-10-29
Last Update Post Date Type: ESTIMATED